Wide Awake Open Carpal Tunnel Release With or Without a Tourniquet
Launched by REGION SKANE · Dec 7, 2023
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a common surgery for carpal tunnel syndrome, which is a condition that causes pain and numbness in the hand due to pressure on a nerve. The study aims to find out whether using a tourniquet (a device to restrict blood flow) during the surgery causes more pain or affects how well patients recover afterward. Participants will be randomly assigned to have the surgery either with a tourniquet or with a different method using local anesthesia that includes adrenaline.
To be eligible for this trial, participants must be 18 years or older and have symptoms of carpal tunnel syndrome without having had similar surgeries before. They should not have certain conditions like previous surgeries on the same hand or specific nerve disorders. The trial is not yet open for recruitment, but it offers a chance for people to potentially help improve surgical options for carpal tunnel syndrome by sharing their experiences.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary idiopathic CTS
- • Age 18 or older
- • Symptoms of classic or probable carpal tunnel syndrome according to Katz hand diagram
- • No previous wide awake hand surgical procedures under local anesthesia
- • No planned concomitant procedures
- Exclusion Criteria:
- • Recurrent carpal tunnel syndrome
- • Vibration induced neuropathy
- • Polyneuropathy
- • Cognitive impairment
- • Anxiety disorder
- • Swedish language insufficiency
- • Active substance abuse
- • Allergy to local anesthesia or adrenaline
- • Patient refusal to participate
About Region Skane
Region Skåne is a leading healthcare authority in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. Committed to fostering collaboration between researchers, healthcare professionals, and patients, Region Skåne aims to enhance the understanding of various health conditions and develop effective treatment strategies. With a focus on ethical standards and patient safety, the organization plays a pivotal role in shaping the future of healthcare in the region and beyond, ensuring that clinical trials are conducted with the highest level of scientific rigor and transparency.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported